Observational Study Aimed at Evaluating the Trend of Neuropathic Pain

NCT06324123 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2024-12-31

No results posted yet for this study

Summary

The present study aims to evaluate the trend of neuropathic pain in patients treated with Peacetil for a period of two months.

Neuropathic pain will me assessed through the Numeric Rating Scale (NRS) questionnaire score.

Conditions

  • Neuropathic Pain

Interventions

OTHER

Peacetil

Nutraceutical supplement Peacetil for a period of 2 months

Sponsors & Collaborators

  • Istituto Auxologico Italiano

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
82 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-09
Primary Completion
2024-06-20
Completion
2024-06-20

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06324123 on ClinicalTrials.gov